Most read articles by the same author(s)

• Anna Bramurska, Magdalena Chełchowska, Lech Chrostek, Olga Ciepiela, Bogdan Cylwik, Agnieszka Ćwiklińska, Łukasz Dąbrowski, Weronika Dwojak, Martyna Feliksiak, Ewa Głąb-Jabłońska, Agnieszka Goryńska, Wiktor Grosz, Ewa Gruszewska, Hanna Gwardiak, Salem Hamdan, Sara Ilkowska, Marzena Iwanowska, Maciej Jankowski, Marcin Kazberuk, Maciej Korpysz, Paweł Kozłowski, Aleksandra Kumorek, Monika Kurek, Michalina Lulek, Anna Multon, Natalia Nazarko, Agata Niewczas, Urszula Nowicka, Alina Olędrzyńska, Anatol Panasiuk, Magdalena Paplińska-Goryca, Monika Paskudzka, Anna Piotrowska, Ewelina Piórkowska, Karolina Pogorzelec, Magdalena Radosz, Mariusz Rozwandowicz, Mariola Sasin-Rokita, Sabina Sobolewska, Anna Stelmaszczyk-Emmel, Katarzyna Szwed, Joanna Taybert, Bartosz Twarowski, Alina Umińska, Małgorzata Wachowska, Szczepan Wąsik, Ewa Wieczorek-Breitzke, Zuzanna Wierzchucka, Małgorzata Wojtkowska, VI JESIEŃ DIAGNOSTYCZNA. MEDYCYNA LABORATORYJNA XXI WIEKU , Prospects in Pharmaceutical Sciences: Vol. 23 No. S1 (2025): „VI JESIEŃ DIAGNOSTYCZNA. MEDYCYNA LABORATORYJNA XXI WIEKU” MRĄGOWO, 21-23 WRZEŚNIA 2025 R.

Similar Articles

• Paulina Dąbrowska, Michał Żuber, Michał Dacka, Efficacy and safety of bempedoic acid in lipid disorder therapy: a review of clinical trials , Prospects in Pharmaceutical Sciences: Vol. 22 No. 3 (2024)
• Nour Mobayed, Dima Joujeh, The therapeutic potential of mesenchymal stromal cells and their secretome in sport-related injuries , Prospects in Pharmaceutical Sciences: Vol. 23 No. 1 (2025)
• Paulina Oleksa, Daria Żuraw, Kacper Jasiński, Mateusz Sobczyk, Mikołaj Porzak, Alicja Sodolska, Karolina Haczkur-Pawłowska, Drugs and other chemical substances inducing diabetes – review of the literature , Prospects in Pharmaceutical Sciences: Vol. 22 No. 2 (2024)
• Maria Rybicka, Anna Seroka, Michał Obrębski, Justyna Chwiejczak, Aleksander Górny, Jan Kościan, Julita Młynarska, Karolina Szczerkowska, Anna Wójcik, Maria Mitkowska, Lipoprotein(a) - gaining clinical importance as a cardiovascular risk factor. Current state of medical knowledge. , Prospects in Pharmaceutical Sciences: Vol. 22 No. 3 (2024)
• Aleksandra Mikulska, Arkadiusz Kocur, Pharmacotherapy with high doses of methotrexate (HDMTX) in oncology – how should chemotherapy be conducted based on therapeutic drug monitoring? , Prospects in Pharmaceutical Sciences: Vol. 21 No. 4 (2023)
• Jakub Olszewski, Katarzyn Kozon, Andrzej Patyra, Flozins in heart failure – a new reimbursement indication , Prospects in Pharmaceutical Sciences: Vol. 20 No. 1 (2022)
• Prathamesh V Chaudhari, Reshma Jadhav, Ashish Jain, Priya D Jagtap, Bhavesh D Mahajan, Prapti Gawand, A comprehensive review on drug-induced diseases and teratogenicity , Prospects in Pharmaceutical Sciences: Vol. 23 No. 1 (2025)
• Bartłomiej Kot, Mateusz Moczulski, Agnieszka Czajkowska, Arkadiusz Kocur, Pharmacotherapy of apnea in the premature neonatological subpopulation – therapeutic opportunities, pharmacokinetic implications and recommendations for therapeutic drug monitoring , Prospects in Pharmaceutical Sciences: Vol. 22 No. 2 (2024)
• Paulina Lis, Anna Lis, Wojciech Kaźmierski, Jakub Jurek, Mateusz Ziomek, Kinga Kocur, Anna Ziobro, Katarzyna Camlet, Inclisiran - a new solution for the prevention and treatment of atherosclerotic cardiovascular disease , Prospects in Pharmaceutical Sciences: Vol. 22 No. 3 (2024)
• Rama Devi Korni, Thanmaisree Bora, Akhil Majji, Jagadeesh Panda, Liquisolid technique for solubility enhancement of a poorly soluble thrombin inhibitor: optimization using design of experiments and artificial neural networks , Prospects in Pharmaceutical Sciences: Vol. 23 No. 3 (2025)

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.